Efficacy of a combined zidovudine plus didanosine therapy in one case of HIV-related thrombocytopenia non-responder to zidovudine alone or to anti-Rho immunoglobulin administration.
Pizzigallo
E
E
Sisto
A
A
Iezzi
A
A
D000209:Acute-Phase Proteins / Q000276:immunology; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D016756:Immunoglobulins, Intravenous; D008297:Male; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use*
D000209:Acute-Phase Proteins; D019380:Anti-HIV Agents; D016756:Immunoglobulins, Intravenous; C010781:acute-phase protein rho; D015215:Zidovudine; D016049:Didanosine